Morning Briefing
Summaries of health policy coverage from major news organizations
High Court: Feds Can Sue Pharmaceutical Companies Over Deals To Delay Generic Drug Sales
The Supreme Court ruled Monday that the Federal Trade Commission can challenge name brand drug makers for potential antitrust violations.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
